Skip to main content
Livermore
Livermore
ZHEN

Aerie Pharmaceuticals Inc

AERIDelisted Nov 21, 2022
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001337553

Aerie Pharmaceuticals Inc was delisted on Nov 21, 2022; its insiders filed their last Form 4 on Nov 21, 2022; 156 institutions reported holding it in 13F filings for Q3 2022, worth $710.6M in total; no superinvestor held it.

Superinvestors holding AERI, Q3 2022

See all superinvestors

No superinvestor reported holding AERI in Q3 2022.

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of AERI each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q4 2021

    0 superinvestors holding at quarter end

    Sold out
    Maverick Capital

  2. Q3 2021

    1 superinvestor holding at quarter end

    Reduced
    Maverick Capital (−80.9%)

  3. Q2 2021

    1 superinvestor holding at quarter end

    Reduced
    Maverick Capital (−8.5%)